(Q47318832)

13 January 2018

title

Tumor growth, weight loss and cytokines in SCID mice (English)

1 reference

13 January 2018

author name string

Murray S

1

1 reference

13 January 2018

Schell K

2

1 reference

13 January 2018

McCarthy DO

3

1 reference

13 January 2018

Albertini MR

4

1 reference

13 January 2018

language of work or name

English

0 references

publication date

1 January 1997

1 reference

13 January 2018

published in

Cancer Letters

1 reference

13 January 2018

volume

111

1 reference

13 January 2018

issue

1-2

1 reference

13 January 2018

page(s)

111-115

1 reference

13 January 2018

A review of cancer cachexia and abnormal glucose metabolism in humans with cancer

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Mechanisms mediating cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Humoral mediation for cachexia in tumour-bearing rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Cancer cachexia is transmissible in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Cytokines and Their Role in the Pathophysiology of Cancer Cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

The Role of Cytokines in Cancer Cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Evidence for the involvement of interleukin 6 in experimental cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Anticachectin/tumor necrosis factor-alpha antibodies attenuate development of cachexia in tumor models

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Anti-tumour necrosis factor-alpha treatment interferes with changes in lipid metabolism in a tumour cachexia model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Interleukin-1 receptor antagonist (IL-1ra) is unable to reverse cachexia in rats bearing an ascites hepatoma (Yoshida AH-130)

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Tumor necrosis factor-alpha mediates changes in tissue protein turnover in a rat cancer cachexia model

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

The effects of cyclooxygenase inhibitors on tumor-induced anorexia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

The presence of tumor necrosis factor-alpha and its antibody in the sera of cachexic patients with gastrointestinal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Weight loss in patients with hematological neoplasias is associated with immune system stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Post-translational regulation of interleukin 1 beta secretion

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

Tumor-derived products induce Il-1 a, Il-1 b, Tnf a, and Il-6 gene expression in murine macrophages: distinctions between tumor- and bacterial endotoxin-induced gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3835%2896%2904519-3

7 January 2021

10.1016/S0304-3835(96)04519-3

Identifiers

DOI

1 reference

13 January 2018

PubMed ID

9022135

1 reference

13 January 2018